- Home
- GERN vs PENG Comparison
GERN vs PENG Comparison
Compare GERN & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- PENG
- Stock Information
- Founded
- GERN 1990
- PENG 1988
- Country
- GERN United States
- PENG Cayman Islands
- Employees
- GERN N/A
- PENG N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- PENG Semiconductors
- Sector
- GERN Health Care
- PENG Technology
- Exchange
- GERN Nasdaq
- PENG Nasdaq
- Market Cap
- GERN 878.9M
- PENG 908.8M
- IPO Year
- GERN 1996
- PENG 2017
- Fundamental
- Price
- GERN $1.27
- PENG $15.88
- Analyst Decision
- GERN Buy
- PENG Strong Buy
- Analyst Count
- GERN 11
- PENG 8
- Target Price
- GERN $5.80
- PENG $24.94
- AVG Volume (30 Days)
- GERN 15.1M
- PENG 1.1M
- Earning Date
- GERN 05-07-2025
- PENG 04-02-2025
- Dividend Yield
- GERN N/A
- PENG N/A
- EPS Growth
- GERN N/A
- PENG N/A
- EPS
- GERN N/A
- PENG N/A
- Revenue
- GERN $76,994,000.00
- PENG $1,318,349,000.00
- Revenue This Year
- GERN $208.83
- PENG $19.41
- Revenue Next Year
- GERN $57.49
- PENG $8.94
- P/E Ratio
- GERN N/A
- PENG N/A
- Revenue Growth
- GERN 32386.92
- PENG 8.05
- 52 Week Low
- GERN $1.19
- PENG $14.20
- 52 Week High
- GERN $5.34
- PENG $29.81
- Technical
- Relative Strength Index (RSI)
- GERN 34.43
- PENG N/A
- Support Level
- GERN $1.17
- PENG N/A
- Resistance Level
- GERN $1.39
- PENG N/A
- Average True Range (ATR)
- GERN 0.13
- PENG 0.00
- MACD
- GERN 0.01
- PENG 0.00
- Stochastic Oscillator
- GERN 21.74
- PENG 0.00
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.